Kevin J. Appelbaum - Chief Executive Officer, Director, 10%+ Owner at Better Therapeutics, Inc.

Insider Transactions and Holdings

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class
Common Stock	2.41M	$409K	$0.17	Mar 31, 2022	By Trust
Common Stock	6.25K	$1.06K	$0.17	Mar 31, 2022	Direct
Stock Option (Right to Buy)	235K			Apr 1, 2022	Direct	Common Stock

Showing 1 to 3 of 3 entries

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.